US 8461155
Sclerostin and the inhibition of WNT signaling and bone formation
granted A61PA61P19/00A61P19/08
Quick answer
US patent 8461155 (Sclerostin and the inhibition of WNT signaling and bone formation) held by UNIVERSITY OF CONNECTICUT expires Mon Jun 06 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- UNIVERSITY OF CONNECTICUT
- Grant date
- Tue Jun 11 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 06 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 2
- CPC classes
- A61P, A61P19/00, A61P19/08, A61P19/10, A61P35/00